Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess toxicities of FLASH radiotherapy treatment and pain relief in subjects with painful thoracic bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.


Clinical Trial Description

This clinical investigation is designed to assess the toxicities of FLASH radiotherapy treatment, as well as pain relief when used to treat bone metastasis(-es) in the thorax. Workflow metrics of FLASH radiotherapy in the thorax in a clinical setting will also be assessed. Patients at least 18 years of age with painful bone metastases located in the thorax will be considered for the study. Eligible subjects will be treated for painful bone metastases in the thorax using a palliative regimen of FLASH radiotherapy and followed post-treatment until subject death or lost to follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05524064
Study type Interventional
Source Varian, a Siemens Healthineers Company
Contact Jennifer Woo
Phone 437-991-3496
Email jennifer.woo@varian.com
Status Recruiting
Phase N/A
Start date March 8, 2023
Completion date April 1, 2025